I was trying to help newbies on another forum and posted

New Post Public Reply Private Reply Replies (1) Message Board
petemantx
1,037
I was trying to help newbies on another forum and posted the below but it was deleted as being off-topic. Well done, SS, you A-hole.

For new people checking out IPIX, it has a lot to offer for both traders and investors.

Traders have made a lot of money due to the constant churning in the share price. Forces seem to want to keep the stock price contained but within a range so that money can be made almost daily as the price rises and settles back down at a fast clip. I am not a trader, don't know much about it, but over the years they have been the BIG winners to date.

As for investors, things have been rough for years due to financial concerns (nothing new when talking about a startup biotech with no products yet and drugs taking 10+ years and about $1B to see thru clinical trials) but events have started to move at a dazzling pace in the last 6 months or so and IPIX seems on the verge of finally capitalizing on its megastar drug, Brilacidin. Brilacidin is a synthetic drug, a defensin mimetic, formulated using tens of thousands of hours on super computers so its benefits are many and its drawbacks very small, if even existent.

Brilacidin is now on a pace to possibly cure all, or at least many, of the most severe lower GI tract problems to include Colitis and Crohn's Disease thru the delivery system of a pill. It is on the verge of going to a PhaseIII trial for Oral Mucositis, has already succeeded in a PhaseII antibiotic trial (ABSSSI), and is currently a leading hope to be a treatment or cure for CV19. It has had tests in governmental bio labs that established that it kills the corona virus, works on human kidney tissue in killing CV, and is nearly finished in testing on how it works regarding human lung tissue. Expectations are quite high, extremely high, for this important lung tissue test due to its past trial history. Then it will be ready for use in human CV trials and Brilacidin should become a worldwide household name. The current testing is expected to result in a lot of money (most think in the 10s of millions) granted to IPIX for furher investigation across many fields. Example: The lung testing, when shown successful, should then lead medical authorities to allow Brilacidin to be tested against COPD and Asthma. Its ability to handle CV should also make it a prime candidate as an adjuvant for ALL other virus vaccines, including the flu. To date, it has NEVER met a bacteria in trials it couldn't kill - to include black plague, about 9 different strains of anthrax, etc.

IPIX also has another drug, Kevetrin, that has shown AMAZING results to date in use as a cancer treatment or adjuvant to ALL current cancer treatments. It is the only current drug that has shown it can activate the p53 gene, named the Guardian Angel gene, as it causes the production of the body's natural defensive agents. It needs to be formulated into a pill and currently the pill is about 1/2 way thru tox tests. It is on hold due to lack of funds to proceed further at the current time. But with the expected government grants on the extremely near horizon (most expect grants within a matter of weeks if lung tissue test results are quite good) the Kevetrin pill will be able to be finished and then be put into quite a battery of trials as a stand alone and, more importantly, as an aid to all other current toxic cancer treatments.

The final piece of the puzzle for BOTH Brilacidin and Kevetrin is that besides showing trial results to date of being extremely effective (efficacious), they are also blessed with safety profiles that are so good, having next to NO negative side effects, that they are marvels in the world of medicine today.

Most the boo-hooing you hear on this board is by the traders as they live and die by the daily share price. The true investors you don't hear much from as the trial results speak for themselves. This investment could be the one of a lifetime if things progress as they have been progressing. But then nothing is ever guaranteed so being such a high risk stock be sure that you don't invest what you can't afford to lose.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New AOF Supplements Boost Human-Model Research

Updated Category News Views 66

Breaking Free from Animal-Derived Components It feels like every biotech firm out there wants to ditch animal components these days, and TheWell Bioscience is no exception. With their new RocketCell™ S1, S2, and S3 supplements, they're diving headlong into the trend of animal origin-free (AOF) cell culture solutions. It's a smart move for researchers frustrated by the...

Continue Reading
Immunic, Inc. Steams Ahead: Phase 3 Trials Hinge on MS Data

Updated Category News Views 17

A Pivotal Moment for Immunic We’re staring down a critical December for Immunic, Inc. as they trot out top-line data for their Phase 3 ENSURE trials aimed at relapsing multiple sclerosis (MS). Now, I’m all ears wondering if those trials can hold water — success could morph them from a tinkering biotech into a commercial giant. For market vultures like us,...

Continue Reading
FF EAI Robotics Aims for Top Spot in K-12 Tech

Updated Category News Views 28

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Continue Reading
Longsys and Lexar Push Boundaries in Edge AI Storage

Updated Category News Views 87

Longsys and Lexar: A Revolution in Storage Ah, the tech world—it's like a fast-moving express train you just can't afford to miss. Longsys and its sidekick Lexar are in the spotlight this time, and boy, they've got some head-turning announcements. At electronica 2026 in Munich, they're playing the storage game hard. From industrial-grade mSSD to automotive solutions,...

Continue Reading
Data Centers: More Power-Hungry Than Thirsty

Updated Category News Views 49

Data Centers: Not Quite the Water Guzzlers We Feared Hold onto your hats, because the latest intel on data centers is changing the game, or at least forcing a closer look at what seems like a done deal. The big reveal? It's not the water, folks—it’s the juice. While everyone frets about water, electricity is the silent giant you’ve got to wrangle. Water vs....

Continue Reading
MENA's Big Digital Investment Hits Policy Roadblocks

Updated Category News Views 25

Heavy digital ambitions in the MENA region The Middle East and North Africa are gearing up for a digital revolution, but not as smoothly as one might hope. Some numbers first—they're throwing an average of 9.3% of revenues into digital transformation efforts through 2032. That's not chump change. Look at UAE and Saudi Arabia, both outpacing the global average, with...

Continue Reading
Curve Dental Pushes Dental Tech with New Marketing Head

Updated Category News Views 67

Curve Dental's Bold Move in Dental Technology Nat Harrison stepping up as Senior VP of Marketing at Curve Dental seems like a big swing for a firm already in the thick of reshaping dental practice management. Curve Dental's advancing platform boasts AI-powered, cloud-native capabilities that aim to streamline operations for dental teams stretched thin by daily demands....

Continue Reading
Innovative Towel Keeps Beachgoers Relaxed and Happy

Updated Category News Views 63

Making Waves at the Beach, Literally Ever been lounging at the beach, wrestling with a rebellious towel that refuses to stay put? A West Coast inventor's tackled that pesky problem head-on with their latest creation: the SECURE LOUNGE TOWEL. From sunny California, this game-changing towel hits you with some serious brainwaves of convenience, keeping that sandy mess at bay...

Continue Reading
HitPaw Shakes Up Black Friday with AI Tool Discounts

Updated Category News Views 50

HitPaw's AI-Powered Black Friday Splash You wake up on a blustery November day, and bam, HitPaw throws down the gauntlet with one mighty tempting Black Friday offer. We're talking about savings running up to a jaw-dropping 60% on some pretty nifty AI-powered creative tools. Now, whether you’re a seasoned content creator or just someone looking to shake up your Instagram...

Continue Reading
Eligible Inc Earns X12 Certification, Boosting Efficiency

Updated Category News Views 87

Highlighting a Key Milestone for Eligible Inc Eligible Inc, that name might not mean much to your average Jane or Joe, but in the inner circles of healthcare administration, it's making serious waves. On November 12, 2026, they proudly announced bagging the X12 Certification Seals for pivotal operations. This ain't just the company handing out participation...

Continue Reading

Top 5 Most Recently Viewed Articles

VIA Optronics and JF Kilfoil Join Forces for Innovation in Displays

Updated Category News Views 187

VIA Optronics AG and JF Kilfoil Form Strategic Partnership VIA optronics AG (OTC: VIAOY), a pioneer in sunlight-readable displays and advanced camera technologies, has announced an exciting new partnership with JF Kilfoil. This collaboration aims to bolster their offerings by combining VIA's innovative display solutions with JF Kilfoil’s extensive reach in the...

Continue Reading
Salesforce's Strategic Acquisition of Own Company Unveiled

Updated Category News Views 202

Salesforce's Bold Move with Own Company Acquisition Salesforce (NYSE: CRM) has recently made waves in the industry by announcing its acquisition of Own Company for an impressive $1.9 billion in cash. This strategic move aims to enhance Salesforce's capabilities in data protection and management, especially as businesses around the globe face increasing risks of data loss...

Continue Reading
Stock Market Midday Update - May 15, 2024

Updated Category Markets Views 326

The most recent market mood today was positively affected by a Consumer Price Index (CPI) report, cooler than predicted. This sparked a rise in US stock prices, as the Federal Reserve felt less pressure to increase interest rates. Yet, individual painted a mixed picture. GameStop and Entertainment Holdings suffered significant drops due to the decrease from previous...

Continue Reading
Paychex's $4.1 Billion Acquisition: A Game-Changer for HR Tech

Updated Category News Views 270

Significant Acquisition in the HR Technology Sector Paychex, Inc. shares are enjoying a positive surge following the announcement of its strategic acquisition of Paycor HCM, Inc. The deal, valued at approximately $4.1 billion, is set to bolster Paychex's capabilities in the realm of AI-driven human resources (HR) solutions. Details of the Acquisition Through this all-cash...

Continue Reading
Discovering Roig Arena: The Pinnacle of Modern Entertainment

Updated Category News Views 312

Roig Arena: Valencia's Largest Indoor Venue Roig Arena has officially opened its doors, establishing itself as the largest indoor venue in Spain. This state-of-the-art facility showcases cutting-edge technology and is designed to host a wide variety of entertainment, corporate, and sports events throughout the year. Unmatched Capacity and Features With a maximum capacity...

Continue Reading